Delivery Order SPE2DB20D3103-SPE2DB24FP4D4

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $7.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,179.34 firm fixed-price delivery order is for the supply of 4566566527 - Sodium Phosphate 45 MMOL/15 ML 15ML, with a completion date of November 29, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This contract award ($7,807.57) is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of a specific medical product - Sodium Phosphate 45 mmol/15 ml, 15 ml. The contract has a firm fixed price and an ultimate completion date of June 25, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,000.66, is a Firm Fixed Price Delivery Order that supports the procurement of 4566998612 - Sodium Phosphate 15 MMOL/5 ML 5ML. The contract has an ultimate completion date of January 22, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,921.74 firm-fixed-price delivery order is for the supply of 15 mmol/5 ml sodium phosphate, a medical product used in various healthcare applications. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,254.28, is for the delivery of sodium phosphate 45 mmol/15 ml in 15 ml vials. The award has an ultimate completion date of August 11, 2023, and is a firm fixed-price contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of SODIUM PHOSPHATE 45 MMOL/15 ML 15ML medical supplies, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,420.21 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 25, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 15 mmol/5 ml sodium phosphate solution, with a ceiling value of $1,993.32 and a performance period through August 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $4,940.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566890507 ! SODIUM PHOSPHATE 45 MMOL/15 ML 15ML, a medical product used in federal healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of January 13, 2025. No set-aside was used for this award. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Delivery Order SPE2DX23FUYXT, valued at $1,256.08, to Amerisourcebergen Drug Corporation's Corporate Office Division. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities worldwide. The awarded delivery order...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 15 mmol/5 ml sodium phosphate, a medical product, with a ceiling value of $2,426.25 and a completion date of December 24, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP4D4
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,490.92 firm fixed-price delivery order is for the supply of 4565069684 - Sodium Phosphate 15 MMOL/5 ML 5ML, with a completion date of July 5, 2024.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is likely tied to the broader IDC, enabling the efficient procurement of critical medical commodities by the DLA. The contract does not have a set-aside designation, indicating open competition. No subcontractors were mentioned in the provided information.

Generated 2/27/25, 11:30 AM